"A leading Brisbane Dermatology practice which participates in clinical trials to assess the efficacy and safety of new treatments for dermatological conditions."

During the past decade, Veracity Clinical Research Pty Ltd conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 26 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 24 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Veracity Clinical Research Pty Ltd" #1 sponsor was "Pfizer" with 12 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "ASLAN Pharmaceuticals" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Veracity Clinical Research Pty Ltd" #1 collaborator was "Incyte Corporation" with 5 trials as a collaborator, "Dermira, Inc." with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Veracity Clinical Research Pty Ltd" are "Atopic Dermatitis" (15 trials), "Psoriasis" (9 trials), "Alopecia Areata" (6 trials), "Dermatitis, Atopic" (4 trials) and "Acne Vulgaris" (3 trials). Many other conditions were trialed in "Veracity Clinical Research Pty Ltd" in a lesser frequency.

Most popular intervention types in "Veracity Clinical Research Pty Ltd" are "Drug" (43 trials), "Biological" (8 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Baricitinib" (5 trials), "Lebrikizumab" (4 trials), "PF-04965842 100 mg" (3 trials) and "PF-04965842 200 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Veracity Clinical Research Pty Ltd" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Veracity Clinical Research Pty Ltd". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Veracity Clinical Research Pty Ltd, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Veracity Clinical Research Pty Ltd, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".